Abstract
Purpose
To evaluate the influence of vitamin D (VD) concentrations coupled with metabolic phenotypes preoperatively and 6 months after Roux-en-Y gastric bypass (RYGB) on body variables and weight loss.
Materials and Methods
A longitudinal, retrospective, analytical study comprising 30 adult individuals assessed preoperatively (T0) and 6 months (T1) after undergoing Roux-en-Y gastric bypass. The participants were distributed preoperatively into metabolically healthy obese (MHO) and metabolically unhealthy obese individuals (MUHO) according to the HOMA-IR classification, as well as the adequacy and inadequacy of vitamin D concentrations in the form of 25(OH)D. All participants were assessed for weight, height, body mass index (BMI), waist circumference (WC), waist-to-height ratio (WHtR), visceral adiposity index (VAI), body circularity index (BCI), body adiposity index (BAI), weight loss, and assessment of 25(OH)D and 1,25(OH)2D concentrations using high-performance liquid chromatography with an ultraviolet detector (HPLC–UV). The statistical program used was SPSS version 21.
Results
VD adequacy and a healthy phenotype in the preoperative period may play an important role concerning body fat distribution, as the body averages for WHtR (0.020*) and BCI (0.020*) were lower in MHO participants. In comparison, those with VD inadequacy and MUHOs had higher BAI averages (0.000*) in the postoperative period. Furthermore, it is possible that VD inadequacy before and after RYGB, even in the presence of an unhealthy phenotype, may contribute to the increase in VAI values (0.029*) after this surgery. Only those with inadequate VD and MUHOs had higher 25(OH)D concentrations. Besides, this unhealthy phenotype had a greater reduction in BMI in the early postoperative period (p < 0.001).
Conclusion
This study suggests that VD adequacy and the presence of a healthy phenotype appear to have a positive impact on the reduction of visceral fat in the context of pre- and postoperative obesity. In addition, there was a greater weight reduction in those with VD inadequacy and in MUHO, which suggests that the volumetric dilution effect of VD and catabolism after bariatric surgery is more pronounced in this specific metabolic phenotype.
Graphical Abstract
Similar content being viewed by others
References
ABESO. (2022). Posicionamento sobre o tratamento nutricional do sobrepeso e da obesidade. https://www.abeso.org.br/posicionamento-nutricional
Bradley LE, Forman EM, Kerrigan SG, et al. Project HELP: a remotely delivered behavioral intervention for weight regain after bariatric surgery. Obes Surg. 2017;27(3):586–98. https://doi.org/10.1007/s11695-016-2337-3.
Bradley LE, Forman EM, Kerrigan SG, et al. A pilot study of an acceptance-based behavioral intervention for weight regain after bariatric surgery. Obes Surg. 2016;26(10):2433–41. https://doi.org/10.1007/s11695-016-2125-0.
Crewe C, An YA, Scherer PE. The ominous triad of adipose tissue dysfunction: inflammation, fibrosis, and impaired angiogenesis. J Clin Invest. 2017;127(1):74–82. https://doi.org/10.1172/JCI88883.
Ferreira FG, Juvanhol LL, da Silva DCG, et al. Visceral adiposity index is a better predictor of unhealthy metabolic phenotype than traditional adiposity measures: results from a population-based study. Public Health Nutr. 2019;22(9):1545–54. https://doi.org/10.1017/S136898001800335X.
Sato F, Maeda N, Yamada T, et al. Association of epicardial, visceral, and subcutaneous fat with cardiometabolic diseases. Circ J. 2018;82:502–8.
Blüher M. Metabolically healthy obesity. Endocr Rev. 2020;41(3):bnaa004. https://doi.org/10.1210/endrev/bnaa004.
Ghaben AL, Scherer PE. Adipogenesis and metabolic health. Nat Rev Mol Cell Biol. 2019;20(4):242–58. https://doi.org/10.1038/s41580-018-0093-z.
Eckel N, Li Y, Kuxhaus O, et al. Transition from metabolic healthy to unhealthy phenotypes and association with cardiovascular disease risk across BMI categories in 90 257 women (the Nurses’ Health Study): 30-year follow-up from a prospective cohort study. Lancet Diabetes Endocrinol. 2018;6(9):714–24. https://doi.org/10.1016/S2213-8587(18)30137-2.
Kuk JLM, Rotondi M, Sui X, et al. Individuals with obesity but no other metabolic risk factors are not at significantly elevated all-cause mortality risk in men and women. Clin Obes. 2018;8(5):305–12.
Stefan N, Schick F, Häring HU. Causes, characteristics, and consequences of metabolically unhealthy normal weight in humans. Cell Metab. 2017;26(2):292–300. https://doi.org/10.1016/j.cmet.2017.07.008.
Karpe F, Pinnick KE. Biology of upper-body and lower-body adipose tissue–link to whole-body phenotypes. Nat Rev Endocrinol. 2015;11(2):90–100. https://doi.org/10.1038/nrendo.2014.185.
González-González JG, Violante-Cumpa JR, Zambrano-Lucio M, et al. HOMA-IR as a predictor of health outcomes in patients with metabolic risk factors: a systematic review and meta-analysis. High Blood Press Cardiovasc Prev. 2022;29(6):547–64. https://doi.org/10.1007/s40292-022-00542-5.
Duan L, Han L, Liu Q, et al. Effects of vitamin D supplementation on general and central obesity: results from 20 randomized controlled trials involving apparently healthy populations. Ann Nutr Metab. 2020;76(3):153–64. https://doi.org/10.1159/000507418.
Alkhatatbeh MJ, Abdul-Razzak KK, Khasawneh LQ, et al. High prevalence of vitamin D deficiency and correlation of serum vitamin D with cardiovascular risk in patients with metabolic syndrome. Metab Syndr Relat Disord. 2017;15(5):213–9. https://doi.org/10.1089/met.2017.0003.
Pereira-Santos M, Costa PR, Assis AM, et al. Obesity and vitamin D deficiency: a systematic review and meta-analysis. Obes Rev. 2015;16(4):341–9. https://doi.org/10.1111/obr.12239.
Holick MF, Binkley NC, Bischoff-Ferrari HA, et al. Guidelines for preventing and treating vitamin D deficiency and insufficiency revisited. J Clin Endocrinol Metab. 2012;97(4):1153–8. https://doi.org/10.1210/jc.2011-2601.
Faludi AA, Izar MCO, Saraiva JFK, et al. Atualização da Diretriz Brasileira de Dislipidemias e Prevenção da Aterosclerose – 2017. Arq Bras Cardiol. 2017;109(2Supl.1):1–76.
American Diabetes Association. Summary of new revision. Diabetes Care. 2022;45.
World Health Organization (WHO). Facts sheet on obesity and overweight. Geneva: World Health Organization; 2017.
WHO Consultation on Obesity (1999: Geneva, Switzerland) & World Health Organization. Obesity: preventing and managing the global epidemic: report of a WHO consultation. World Health Organization. 2000. Available at: https://iris.who.int/handle/10665/42330
Ukoli FA, et al. Body fat distribution and other anthropometric blood pressure correlate in a Nigerian urban elderly population. Central Afr J Med (CAJM). 2000;41(5):154–161. UZ, Mt. Pleasant, Harare; Faculty of Medicine
de Groot LC, Sette S, Zajkás G, et al. Nutritional status: anthropometry. Euronut SENECA investigators. Eur J Clin Nutr. 1991;45(Suppl 3):31–42.
Sousa TF. Atividadesfísicas praticadas no lazer por universitários de uma instituição pública do Nordeste do Brasil. Rev Bras Ativ Fis Saúde. 2011.
Zeng Q, He Y, Dong S, et al. Optimal cut-off values of BMI, waist circumference and waist:height ratio for defining obesity in Chinese adults. Br J Nutr. 2014;112(10):1735–44. https://doi.org/10.1017/S0007114514002657.
Gofin J, Abramson JH, Kark JD, et al. The prevalence of obesity and its changes over time in middle-aged and elderly men and women in Jerusalem.Int J Obes. 1996.
Bergman RN, Stefanovski D, Buchanan TA, et al. A better index of body adiposity. Obesity (Silver Spring). 2011;19:1083–9.
Gonçalves R, Mascarenhas LPG, Liebl EC, et al. Grau de concordância do IMC e do IAC com percentual de gordura corporal. Rev Bras Qualidade Vida. 2014;6(1):8–16.
Amato MC, Giordano C, Galia M, et al. Visceral Adiposity Index: a reliable indicator of visceral fat function associated with cardiometabolic risk. Diabetes Care. 2010;33(4):920–2. https://doi.org/10.2337/dc09-1825.
de Koning L, Merchant AT, Pogue J. Waist circumference and waist-to-hip ratio as predictors of cardiovascular events: meta-regression analysis of prospective studies. Eur Heart J. 2007;28(7):850–6. https://doi.org/10.1093/eurheartj/ehm026.
Amato MC, Giordano C, Pitrone M, et al. Cut-off points of the visceral adiposity index (VAI) identifying a visceral adipose dysfunction associated with cardiometabolic risk in a Caucasian Sicilian population. Lipids Health Dis. 2011;10:183.
Vongsuvanh R, George J, McLeod D, et al. Visceral adiposity index is not a predictor of liver histology in patients with non-alcoholic fatty liver disease. J Hepatol. 2012;57(2):392–8.
Thomas DM, Bredlau C, Bosy-Westphal A, et al. Relationships between body roundness with body fat and visceral adipose tissue emerging from a new geometrical model. Obesity (Silver Spring). 2013;21(11):2264–71. https://doi.org/10.1002/oby.20408.
Gumbs AA, Gagner M, Dakin G, et al. Sleeve gastrectomy for morbid obesity. Obes Surg. 2007;17(7):962–9. https://doi.org/10.1007/s11695-007-9151-x.
Cummings GG, MacGregor T, Davey M, et al. Leadership styles and outcome patterns for the nursing workforce and work environment: a systematic review. Int J Nurs Stud. 2010;47(3):363–85. https://doi.org/10.1016/j.ijnurstu.2009.08.006.
Rocha Q, Mendonça S, Fortes R. Perda Ponderal após Gastroplastia em Y de Roux e Importância do acompanhamento nutricional – Uma revisão de literatura. Ciências Saúde. 2011;22(1):61–70.
Standards of Care in Diabetes-2023 Abridged for primary care providers. Standards of care in diabetes - 2023. Abridged for primary care providers. Clin Diabetes. 2022 Winter;41(1):4–31. https://doi.org/10.2337/cd23-as01.
Xavier HT, Izar MC, Faria Neto JR, et al. V Diretriz brasileira de dislipidemias e prevenção da aterosclerose. Arq Bras Cardiol. 2013;101:1–20.
Dorsey JG, Cooper WT. Retention mechanisms of bonded-phase liquid chromatography. Anal Chem. 1994;17:857–67.
Karelis AD, Faraj M, Bastard JP, et al. The metabolically healthy but obese individual presents a favorable inflammation profile. J Clin Endocrinol Metabol. 2005;90:4145–50.
Karelis AD, Rabasa-Lhoret R. Characterization of metabolically healthy but obese individuals: should we add vitamin D to the puzzle? Diabetes Metab. 2014;40:319–21.
da Cruz SP, Cruz S, Pereira S, et al. Adequacy and vitamin D in the preoperative period of Roux-en-Y gastric bypass, bariatric surgery, can protect metabolic health in metabolically healthy and unhealthy individuals. Nutrients. 2022;14:402. https://doi.org/10.3390/nu14030402.
Dominoni LADC, Gabiatti MP, Piazza FRG, et al. Vitamin D is associated with body composition and fat intake, but not with cardiometabolic parameters in adults with obesity. Nutr Res. 2022;105:97–104. https://doi.org/10.1016/j.nutres.2022.06.006.
Farrell SW, Pavlovic A, Barlow CE, et al. Desempenho na triagem funcional do movimento e associação com os principais marcadores de saúde em idosos. J Força Cond Res. 2021;35(11):3021–7. https://doi.org/10.1519/JSC.0000000000003273.
Pantovic A, Zec M, Zekovic M, et al. Vitamin D is inversely related to obesity: cross-sectional study in a small cohort of Serbian adults. J Am Coll Nutr. 2019;38(5):405–14. https://doi.org/10.1080/07315724.2018.1538828.
Jonas MI, Kuryłowicz A, Bartoszewicz Z, et al. Vitamin D receptor gene expression in adipose tissue of obese individuals is regulated by miRNA and correlates with the pro-inflammatory cytokine level. Int J Mol Sci. 2019;20:5272. https://doi.org/10.3390/ijms20215272.
Wamberg L, Kampmann U, Stødkilde-Jørgensen H, et al. Effects of vitamin D supplementation on body fat accumulation, inflammation, and metabolic risk factors in obese adults with low vitamin D levels - results from a randomized trial. Eur J Intern Med. 2013;24(7):644–9. https://doi.org/10.1016/j.ejim.2013.03.005.
Clemente-Postigo M, Roca-Rodriguez M del M, Camargo A, et al. Lipopolysaccharide and lipopolysaccharide-binding protein levels and their relationship to early metabolic improvement after bariatric surgery. Surg Obes Relat Dis. 2015;11(4):933-9. https://doi.org/10.1016/j.soard.2014.11.030.
Zoico E, Franceschetti G, Chirumbolo S, et al. Phenotypic shift of adipocytes by cholecalciferol and 1α,25 dihydroxycholecalciferol in relation to inflammatory status and calcium content. Endocrinology. 2014;155(11):4178–88. https://doi.org/10.1210/en.2013-1969.
Elkhwanky MS, Kummu O, Piltonen TT, et al. Obesity represses CYP2R1, the vitamin D 25-hydroxylase, in the liver and extrahepatic tissues. JBMR Plus. 2020;4(11):e10397. https://doi.org/10.1002/jbm4.10397.
Carrelli A, Bucovsky M, Horst R, et al. Vitamin D storage in adipose tissue of obese and normal weight women. J Bone Miner Res. 2017;32(2):237–42. https://doi.org/10.1002/jbmr.2979.
Beckman LM, Earthman CP, Thomas W, et al. Serum 25(OH) Vitamin D concentration changes after Roux-en-Y gastric bypass surgery. Obesity. 2013;21(12):E599–606. https://doi.org/10.1002/oby.20464.
Ghashut RA, Talwar D, Kinsella J, et al. The effect of the systemic inflammatory response on plasma vitamin 25 (OH) D concentrations adjusted for albumin. PLoS One. 2014;9(3):e92614. https://doi.org/10.1371/journal.pone.0092614.
Hajhashemy Z, Shahdadian F, Ziaei R, et al. Níveis séricos de vitamina D em relação à obesidade abdominal: Uma revisão sistemática e meta-análise dose-resposta de estudos epidemiológicos. Obes Rev. 2021;22(2):e13134. https://doi.org/10.1111/obr.13134.
Williams SE. Metabolic bone disease in the bariatric surgery patient. J Obes. 2011;2011:634614. https://doi.org/10.1155/2011/634614.
Xanthakos SA. Nutritional deficiencies in obesity and after bariatric surgery. Pediatr Clin North Am. 2009;56(5):1105–21. https://doi.org/10.1016/j.pcl.2009.07.002.
Farrell SW, Pavlovic A, Barlow CE, et al. Desempenho na triagem funcional do movimento e associação com os principais marcadores de saúde em idosos. J Força Cond Res. 2021;35(11):3021–7. https://doi.org/10.1519/JSC.0000000000003273.
Pantovic A, et al. Vitamin D is inversely related to obesity: cross-sectional study in a small cohort of Serbian adults. J Am Coll Nutr. 2019;38(5):405–14.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Ethical Approval
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.
Conflict of Interest
The authors declare no competing interests.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
da Cruz, S.P., da Cruz, S.P., Pereira, S. et al. Vitamin D and the Metabolic Phenotype in Weight Loss After Bariatric Surgery: A Longitudinal Study. OBES SURG 34, 1561–1568 (2024). https://doi.org/10.1007/s11695-024-07148-x
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11695-024-07148-x